Unknown

Dataset Information

New Ameloblastoma Cell Lines Enable Preclinical Study of Targeted Therapies.


ABSTRACT: Ameloblastoma (AB) is an odontogenic tumor that arises from ameloblast-lineage cells. Although relatively uncommon and rarely metastatic, AB tumors are locally invasive and destructive to the jawbone and surrounding structures. Standard-of-care surgical resection often leads to disfigurement, and many tumors will locally recur, necessitating increasingly challenging surgeries. Recent genomic studies of AB have uncovered oncogenic driver mutations, including in the mitogen-activated protein kinase (MAPK) and Hedgehog signaling pathways. Medical therapies targeting those drivers would be a highly desirable alternative or addition to surgery; however, a paucity of existing AB cell lines has stymied clinical translation. To bridge this gap, here we report the establishment of 6 new AB cell lin

SUBMITTER: Nguyen J 

PROVIDER: S-EPMC9608093 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature